DK1664093T3 - Antitumorforbindelser baseret på kahalalid F - Google Patents

Antitumorforbindelser baseret på kahalalid F

Info

Publication number
DK1664093T3
DK1664093T3 DK04768394T DK04768394T DK1664093T3 DK 1664093 T3 DK1664093 T3 DK 1664093T3 DK 04768394 T DK04768394 T DK 04768394T DK 04768394 T DK04768394 T DK 04768394T DK 1664093 T3 DK1664093 T3 DK 1664093T3
Authority
DK
Denmark
Prior art keywords
kahalalide
compounds based
tumor compounds
tumor
new analogues
Prior art date
Application number
DK04768394T
Other languages
English (en)
Inventor
Garcia Jose-Carlos Jimenez
Palomera Fernando Albericio
Donis Ariadna Fernandez
Cantador Carolina Gracia
Rodriguez Pilar Lopez
Colomer Sonia Varon
Marchante Carmen Cuevas
Macia Angel Lopez
Solloso Andres Francesch
Exposito Miriam Royo
Lledo Ernest Giralt
Original Assignee
Pharma Mar Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sau filed Critical Pharma Mar Sau
Application granted granted Critical
Publication of DK1664093T3 publication Critical patent/DK1664093T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK04768394T 2003-09-09 2004-09-09 Antitumorforbindelser baseret på kahalalid F DK1664093T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0321066.3A GB0321066D0 (en) 2003-09-09 2003-09-09 New antitumoral compounds
PCT/GB2004/003847 WO2005023846A1 (en) 2003-09-09 2004-09-09 New antitumoral compounds

Publications (1)

Publication Number Publication Date
DK1664093T3 true DK1664093T3 (da) 2008-08-18

Family

ID=29226738

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13180582.2T DK2664623T3 (da) 2003-09-09 2004-09-09 Nye antitumorale forbindelser
DK04768394T DK1664093T3 (da) 2003-09-09 2004-09-09 Antitumorforbindelser baseret på kahalalid F

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK13180582.2T DK2664623T3 (da) 2003-09-09 2004-09-09 Nye antitumorale forbindelser

Country Status (23)

Country Link
US (1) US20070117743A1 (da)
EP (6) EP2280027A3 (da)
JP (4) JP4874796B2 (da)
KR (1) KR20060073618A (da)
CN (2) CN101531707A (da)
AT (1) ATE393776T1 (da)
AU (2) AU2004270471B2 (da)
CA (1) CA2537128A1 (da)
CY (1) CY1108226T1 (da)
DE (1) DE602004013454T2 (da)
DK (2) DK2664623T3 (da)
ES (2) ES2305843T3 (da)
GB (1) GB0321066D0 (da)
HR (1) HRP20080330T3 (da)
HU (1) HUE025308T2 (da)
IL (1) IL173929A (da)
MX (1) MXPA06002741A (da)
NZ (4) NZ580124A (da)
PL (1) PL1664093T3 (da)
PT (1) PT1664093E (da)
RU (2) RU2395520C2 (da)
SI (1) SI1664093T1 (da)
WO (1) WO2005023846A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
GB0304367D0 (en) 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
WO2009052379A2 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
EP2252315A1 (en) * 2008-01-30 2010-11-24 Pharma Mar, S.A. Improved antitumoral treatments
EP2262522A1 (en) * 2008-03-07 2010-12-22 Pharma Mar, S.A. Improved antitumoral treatments
CN101519437B (zh) * 2009-04-09 2012-05-02 中国人民解放军第二军医大学 西沙海绵中一种环七肽类化合物及其用途
CN104725266B (zh) * 2014-04-10 2016-08-10 申俊 酰亚胺类化合物的合成方法
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22545A1 (es) * 1994-11-18 1999-03-31 Centro Inmunologia Molecular Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
US4943533A (en) * 1984-03-01 1990-07-24 The Regents Of The University Of California Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
JPS6178719A (ja) * 1984-09-25 1986-04-22 Tanabe Seiyaku Co Ltd 総合輸液剤
DK0531472T3 (da) * 1991-03-06 2003-12-01 Merck Patent Gmbh Humaniserede monoklonale antistoffer
GB9300059D0 (en) * 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
GB9302046D0 (en) 1993-02-03 1993-03-24 Pharma Mar Sa Antiumoral compound-v
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
US5747498A (en) * 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
EP0912559B1 (en) * 1996-07-13 2002-11-06 Glaxo Group Limited Fused heterocyclic compounds as protein tyrosine kinase inhibitors
US6235883B1 (en) * 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
GB9800569D0 (en) * 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
US6200598B1 (en) * 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
WO2000031048A1 (en) * 1998-11-19 2000-06-02 Warner-Lambert Company N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
US7311924B2 (en) * 1999-04-01 2007-12-25 Hana Biosciences, Inc. Compositions and methods for treating cancer
UA74803C2 (uk) * 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
MXPA03003704A (es) 2000-10-31 2004-05-04 Pharma Mar Sa Formulacion de kahalalide f.
AU2002334203C1 (en) 2001-10-19 2008-10-09 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy
CN100591691C (zh) 2002-10-18 2010-02-24 马尔药品公司 新型抗肿瘤化合物
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
SI1572726T1 (sl) * 2002-10-18 2011-04-29 Pharma Mar Sau 4-metilheksanoiäśna kahalalid f spojina
US7507708B2 (en) * 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds

Also Published As

Publication number Publication date
EP1918296A2 (en) 2008-05-07
AU2011202286A1 (en) 2011-06-09
PT1664093E (pt) 2008-08-07
EP1664093B8 (en) 2008-08-13
HUE025308T2 (en) 2016-01-28
RU2395520C2 (ru) 2010-07-27
JP4874796B2 (ja) 2012-02-15
US20070117743A1 (en) 2007-05-24
JP5372096B2 (ja) 2013-12-18
PL1664093T3 (pl) 2008-10-31
SI1664093T1 (sl) 2008-12-31
CN1849333A (zh) 2006-10-18
CN101531707A (zh) 2009-09-16
JP2012031188A (ja) 2012-02-16
MXPA06002741A (es) 2006-06-05
EP1918296B1 (en) 2012-11-14
EP1664093A1 (en) 2006-06-07
EP2280026A2 (en) 2011-02-02
CY1108226T1 (el) 2014-02-12
DE602004013454D1 (de) 2008-06-12
WO2005023846A1 (en) 2005-03-17
HRP20080330T3 (en) 2009-04-30
DK2664623T3 (da) 2015-05-11
NZ580124A (en) 2011-01-28
EP2664623B1 (en) 2015-03-04
DE602004013454T2 (de) 2009-06-18
CA2537128A1 (en) 2005-03-17
GB0321066D0 (en) 2003-10-08
EP2280025A2 (en) 2011-02-02
RU2006111491A (ru) 2007-11-20
EP2280026A3 (en) 2011-05-25
EP1664093B1 (en) 2008-04-30
JP2012031187A (ja) 2012-02-16
IL173929A0 (en) 2006-07-05
KR20060073618A (ko) 2006-06-28
ATE393776T1 (de) 2008-05-15
EP2280025A3 (en) 2011-05-25
EP2280027A2 (en) 2011-02-02
JP2007526904A (ja) 2007-09-20
JP2012051899A (ja) 2012-03-15
IL173929A (en) 2014-01-30
ES2536285T3 (es) 2015-05-22
AU2004270471B2 (en) 2011-06-02
CN100467482C (zh) 2009-03-11
RU2009147217A (ru) 2011-06-27
AU2011202286B2 (en) 2013-08-01
NZ545700A (en) 2010-03-26
EP1918296A3 (en) 2009-06-24
NZ589890A (en) 2011-11-25
NZ595490A (en) 2013-04-26
ES2305843T3 (es) 2008-11-01
AU2004270471A1 (en) 2005-03-17
EP2664623A1 (en) 2013-11-20
EP2280027A3 (en) 2011-05-04

Similar Documents

Publication Publication Date Title
DE60303328D1 (de) Ringförmige Lichtquelle
DK1847611T3 (da) Rhamnose-inducerbart ekspressionssystem
DE60336538D1 (de) Stabilisiervorrichtung
DE60313964D1 (de) Einzelphotonenquelle
DE60318624D1 (de) Lastträgerfuss
NO20054669D0 (no) Substituerte kinobenzoxazinanaloger
CY1108226T1 (el) Αντικαρκινικες ενωσεις βασισμενες σε καχαλαλιδης f
GB0211161D0 (en) Millimetre-wave illumination source
ITMI20022022A1 (it) Analoghi di nocicettina.
DE602004032105D1 (de) Elektronenquelle
DE602004025757D1 (de) Flexibler Träger
ITRM20020434A1 (it) Procedimento per la sintesi di zolfo polimerico.
CY1105699T1 (el) Νεες φαρμακευτικες ενωσεις με αλφα2υποδοχεα δραστηριοτητας
ITMI20031904A1 (it) Lampada abbronzante.
FI20021234A7 (fi) Kasvunedistäjä
FR2856807B1 (fr) Source lumineuse.
CY1115144T1 (el) Παραγωγα του uk-2a
ITFO20030011A1 (it) Paratia removibile antialluvione.
ES1051818Y (es) Fuente.
SK3735U (sk) Štartovací zdroj
FI20022201A0 (fi) Aromilähde
ES1052699Y (es) Piragua desmontable.
ITMI20022591A1 (it) Compasso.
ES1052131Y (es) Luminaria estanca mejorada.
ITMI20031905A1 (it) Procedimento per la produzione di pellame.